Viewing Study NCT00835692


Ignite Creation Date: 2025-12-24 @ 3:36 PM
Ignite Modification Date: 2026-03-08 @ 12:25 AM
Study NCT ID: NCT00835692
Status: COMPLETED
Last Update Posted: 2024-08-20
First Post: 2009-02-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Clarithromycin 500 mg Tablets Under Fasting Conditions
Sponsor: Teva Pharmaceuticals USA
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: R02-663
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators